Home › Hypoparathyroidism › North Carolina › Greenville
Hypoparathyroidism clinical trials in Greenville, NC
3 studies for Hypoparathyroidism are looking for participants at sites in and around Greenville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
RecruitingPhase 3
- Ascendis Pharma Investigational Site, Greenville
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
RecruitingPhase 3
- MBX Biosciences Investigational Site, Greenville
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
RecruitingPhase 3
- Calcilytix Therapeutics, Inc., a BridgeBio Company, Investigational Site, Greenville
Hypoparathyroidism trials in other cities
Other studies in Greenville
- Acute Myeloid Leukemia10 studies
- Sickle Cell Disease9 studies
- Idiopathic Thrombocytopenic Purpura6 studies
- Heart Failure6 studies
- Chronic Lymphocytic Leukemia5 studies
- Burkitt Lymphoma5 studies
- Obesity5 studies
- Type 2 Diabetes5 studies
- Blood Disorders5 studies
- Cancer (all types)4 studies
- Autoimmune Diseases4 studies
- Myeloproliferative Neoplasms4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.